Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAP3K5 | Q99683 | 4/20 | 0.65 |
| ▸ | PABPC1 | P11940 | 3/20 | 0.54 |
| ▸ | MAPT | P10636 | 10/20 | 0.53 |
| ▸ | SMN1; SMN2 | Q16637 | 4/20 | 0.53 |
| ▸ | NR4A1 | P22736 | 1/20 | 0.51 |
| ▸ | MEN1 | O00255 | 12/20 | 0.49 |
| ▸ | KMT2A | Q03164 | 12/20 | 0.49 |
| ▸ | POLB | P06746 | 6/20 | 0.49 |
| ▸ | L3MBTL1 | Q9Y468 | 4/20 | 0.49 |
| ▸ | USP2 | O75604 | 6/20 | 0.44 |
| ▸ | MAPK1 | P28482 | 3/20 | 0.44 |
| ▸ | GAA | P10253 | 3/20 | 0.44 |
| ▸ | HPGD | P15428 | 2/20 | 0.44 |
| ▸ | BLM | P54132 | 2/20 | 0.44 |
| ▸ | PKM | P14618 | 1/20 | 0.44 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.44 |
| ▸ | TSHR | P16473 | 1/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.43 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.43 |
| ▸ | KEAP1 | Q14145 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14559159 | 0.95 | MAP3K5 (0.61) | MAP3K5PABPC1MAPTSMN1; SMN2NR4A1 | |
| SCHEMBL10033596 | 0.91 | MAP3K5 (0.57) | MAP3K5PABPC1MAPTSMN1; SMN2NR4A1 | |
| SCHEMBL17808464 | 0.90 | MAP3K5 (0.56) | MAP3K5PABPC1MAPTSMN1; SMN2NR4A1 | |
| SCHEMBL10098484 | 0.90 | MAP3K5 (0.59) | MAP3K5PABPC1MAPTSMN1; SMN2NR4A1 | |
| SCHEMBL966625 | 0.90 | MAP3K5 (0.58) | MAP3K5PABPC1MAPTSMN1; SMN2NR4A1 | |
| SCHEMBL20682157 | 0.87 | MAP3K5 (0.59) | MAP3K5PABPC1MAPTSMN1; SMN2NR4A1 | |
| SCHEMBL17813950 | 0.85 | MAP3K5 (0.57) | MAP3K5PABPC1MAPTSMN1; SMN2NR4A1 | |
| SCHEMBL13382720 | 0.85 | MEN1 (0.66) | MAP3K5PABPC1MAPTSMN1; SMN2NR4A1 | |
| SCHEMBL11891998 | 0.84 | MAP3K5 (0.52) | MAP3K5PABPC1MAPTSMN1; SMN2NR4A1 | |
| SCHEMBL17808610 | 0.84 | MAP3K5 (0.49) | MAP3K5PABPC1MAPTSMN1; SMN2NR4A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20160160065-A1 | INK COMPOSITION, INK JET RECORDING METHOD USING SAME, AND COLORED MATERIAL | NIPPON KAYAKU KABUSHIKI KAISHA (JP) | 2016-06-09 | — | — | US | disclosed |
| US-20120056931-A1 | MAGENTA COLORING MATTER, INK COMPOSITION, AND COLORED BODY | NIPPON KAYAKU KABUSHIKI KAISHA (JP) | 2012-03-08 | — | — | US | disclosed |
| US-20120056931-A1 | MAGENTA COLORING MATTER, INK COMPOSITION, AND COLORED BODY | NIPPON KAYAKU KABUSHIKI KAISHA (JP) | 2012-03-08 | — | — | US | disclosed |
| US-20110195238-A1 | ANTHRAPYRIDONE COLORING MATTER, SALT THEREOF, INK COMPOSITION AND COLORED BODY | NIPPON KAYAKU KABUSHIKI KAISHA (JP) | 2011-08-11 | — | — | US | disclosed |
| US-20110195238-A1 | ANTHRAPYRIDONE COLORING MATTER, SALT THEREOF, INK COMPOSITION AND COLORED BODY | NIPPON KAYAKU KABUSHIKI KAISHA (JP) | 2011-08-11 | — | — | US | disclosed |
| US-7909926-B2 | Ink composition and colored product | NIPPON KAYAKU KABUSHIKI KAISHA (JP) | 2011-03-22 | — | — | US | disclosed |
| US-7909926-B2 | Ink composition and colored product | NIPPON KAYAKU KABUSHIKI KAISHA (JP) | 2011-03-22 | — | — | US | disclosed |
| US-20090324900-A1 | INK COMPOSITION AND COLORED PRODUCT | NIPPON KAYAKU KABUSHIKI KAISHA (JP) | 2009-12-31 | — | — | US | disclosed |
| US-20090324900-A1 | INK COMPOSITION AND COLORED PRODUCT | NIPPON KAYAKU KABUSHIKI KAISHA (JP) | 2009-12-31 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110195238-A1 | ANTHRAPYRIDONE COLORING MATTER, SALT THEREOF, INK COMPOSITION AND COLORED BODY | XDH, HAX1, ANXA1 | MAP3K5 2261/4885PABPC1 1264/4885MAPT 2210/4885 |
| US-20090324900-A1 | INK COMPOSITION AND COLORED PRODUCT | ATXN2, IK, AURKA | MAP3K5 67/4885PABPC1 1856/4885MAPT 1751/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.